ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

124
Analysis
Health Care • Hong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
bullish•PointsBet Holdings
•30 Jul 2025 11:59

PointsBet (PBH AU): Either Betr Pulls A Rabbit Out Of The Hat, Or Walks

I can see Mixi waiving the acceptance condition and declaring term unconditional. Trading at terms. If in, sell here. If not in, avoid unless...

Logo
316 Views
Share
•28 Jul 2025 10:28

Ainsworth Game Technology (AGI AU): 29th August Vote On Novomatic's "Low-Balled Offer"

I think this gets up. And that's a chunky franked dividend with respect to the Offer price. For those who can take advantage. Key shareholders have...

Logo
455 Views
Share
bullish•Shibaura Electronics
•28 Jul 2025 02:03

Merger Arb Mondays (28 Jul) - Shibaura, Abacus Storage, Insignia, Mayne, Santos, ENN, Smart Share

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
950 Views
Share
bearish•CK Hutchison Holdings
•27 Jul 2025 09:44

Weekly Deals Digest (27 Jul) - CK Hutchison, Pacific Industrial, FHT, Abacus, PointsBet, NSDL

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
481 Views
Share
bullish•Insignia Financial
•27 Jul 2025 05:15

(Mostly) Asia-Pac M&A: Pacific Ind., Insignia Fin., PointsBet, New World Res., Frasers Hospitality

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
594 Views
Share
x